🎓 Conference Programme

• 8:30 – 9:00 | Registration & Coffee
• 9:00 – 9:20 | Welcome Address

Presented by the Organizing Committee, Gentaur Molecular Products

📅 Session I: Advancing Scientific Confidence in Biosimilars (9:20 – 10:40)

• From Biologics to Biosimilars: Key Principles and Analytical Comparability

Dr. Sophie Delcourt — Head of Biotherapeutics, VIB Leuven, Belgium

• Case Study: Molecular Consistency and Functional Equivalence

Dr. Alain Vandervoort — Principal Scientist, Biologics QC, Liège Biotech Cluster

• 10:40 – 11:00 | Morning Break & Networking

📊 Session II: Navigating European Regulatory Requirements (11:00 – 12:30)

• EMA's Current Framework and the Role of Real-World Evidence

Isabelle Dupuis — Regulatory Affairs Manager, European Medicines Agency (EMA)

• Biomarker Strategies for Biosimilar Monoclonals

Dr. Lars Henriksen — Medical Reviewer, Danish Medicines Agency

• Q&A Panel with Speakers
• 12:30 – 14:00 | Lunch Break

🌟 Session III: Preclinical Tools and Technologies for Biosimilar Evaluation (14:00 – 15:30)

• In Vitro Functional Assays for mAb Biosimilars

Dr. Petra Janssen — Lead Scientist, Gentaur Molecular Assay Unit

• Bioanalytical Platforms: From Fc Receptor Binding to ADCC Readouts

Marc Eyskens — Biologics Division, Sciensano

• Formulation Advances to Enhance Stability and Shelf Life

Dr. Claire Lefevre — Formulation Chemist, UCB Pharma

• 15:30 – 15:50 | Coffee Break

🚀 Session IV: Societal Trust and Adoption of Biosimilars (15:50 – 17:00)

Public Perception and Physician Confidence in Biosimilars

Prof. Tom Willems — Faculty of Pharmaceutical Sciences, KU Leuven

Panel Discussion: Building a Stronger Biosimilar Future in Belgium

Moderated by Julie Meyers, Bio.be/essenscia

📝 Registration & Information

Seats are limited. Register now to be part of Belgium’s leading discussion on biosimilar antibody advancement.

📧 Contact: info@gentaur.com

🌐 Register : Contact Us

Organized by Gentaur Molecular Products — Shaping the Future of Biosimilar Research